In most cases the gastrointestinal symptoms associated with both azithromycin regimens were classed as mild to moderate in intensity. The rates of treatment discontinuation because of adverse ...
We are pleased to announce that our applications for the higher dose regimen of nusinersen are now under review in the US and Europe,” said Stephanie Fradette, Pharm.D., Head of the Neuromuscular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback